Logo image of APVO

APTEVO THERAPEUTICS INC (APVO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:APVO - US03835L5049 - Common Stock

9.29 USD
-0.54 (-5.49%)
Last: 1/21/2026, 8:00:00 PM
9.2383 USD
-0.05 (-0.56%)
After Hours: 1/21/2026, 8:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to APVO. APVO was compared to 525 industry peers in the Biotechnology industry. While APVO seems to be doing ok healthwise, there are quite some concerns on its profitability. APVO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year APVO has reported negative net income.
  • APVO had a negative operating cash flow in the past year.
  • APVO had negative earnings in 4 of the past 5 years.
  • APVO had a negative operating cash flow in each of the past 5 years.
APVO Yearly Net Income VS EBIT VS OCF VS FCFAPVO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

  • APVO's Return On Assets of -103.54% is on the low side compared to the rest of the industry. APVO is outperformed by 76.00% of its industry peers.
  • APVO has a worse Return On Equity (-160.72%) than 65.14% of its industry peers.
Industry RankSector Rank
ROA -103.54%
ROE -160.72%
ROIC N/A
ROA(3y)-66.85%
ROA(5y)-56.8%
ROE(3y)-200.85%
ROE(5y)-609.94%
ROIC(3y)N/A
ROIC(5y)N/A
APVO Yearly ROA, ROE, ROICAPVO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

  • APVO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
APVO Yearly Profit, Operating, Gross MarginsAPVO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

More info and screens

6

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, APVO has more shares outstanding
  • Compared to 5 years ago, APVO has more shares outstanding
  • APVO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
APVO Yearly Shares OutstandingAPVO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500 1K 1.5K
APVO Yearly Total Debt VS Total AssetsAPVO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -6.12, we must say that APVO is in the distress zone and has some risk of bankruptcy.
  • APVO's Altman-Z score of -6.12 is on the low side compared to the rest of the industry. APVO is outperformed by 63.81% of its industry peers.
  • There is no outstanding debt for APVO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -6.12
ROIC/WACCN/A
WACCN/A
APVO Yearly LT Debt VS Equity VS FCFAPVO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 4.03 indicates that APVO has no problem at all paying its short term obligations.
  • APVO has a Current ratio (4.03) which is in line with its industry peers.
  • APVO has a Quick Ratio of 4.03. This indicates that APVO is financially healthy and has no problem in meeting its short term obligations.
  • APVO has a Quick ratio (4.03) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 4.03
APVO Yearly Current Assets VS Current LiabilitesAPVO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 74.75% over the past year.
EPS 1Y (TTM)74.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • APVO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.87% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y99.95%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5Y14.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
APVO Yearly Revenue VS EstimatesAPVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2029 2030 2031 2032 50M 100M 150M
APVO Yearly EPS VS EstimatesAPVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -500K -1M -1.5M -2M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • APVO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for APVO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
APVO Price Earnings VS Forward Price EarningsAPVO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
APVO Per share dataAPVO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1K -2K -3K

4.3 Compensation for Growth

  • A more expensive valuation may be justified as APVO's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

  • APVO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

APTEVO THERAPEUTICS INC

NASDAQ:APVO (1/21/2026, 8:00:00 PM)

After market: 9.2383 -0.05 (-0.56%)

9.29

-0.54 (-5.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)02-12
Inst Owners0.16%
Inst Owner Change0%
Ins Owners0%
Ins Owner Change2.09%
Market Cap156.54M
Revenue(TTM)N/A
Net Income(TTM)-27.95M
Analysts82.86
Price Target7711.2 (82905.38%)
Short Float %N/A
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)51.43%
Min EPS beat(2)12.75%
Max EPS beat(2)90.1%
EPS beat(4)2
Avg EPS beat(4)-210.34%
Min EPS beat(4)-942%
Max EPS beat(4)90.1%
EPS beat(8)6
Avg EPS beat(8)-73.73%
EPS beat(12)9
Avg EPS beat(12)-32.62%
EPS beat(16)12
Avg EPS beat(16)6.37%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1700%
PT rev (3m)1700%
EPS NQ rev (1m)-1700%
EPS NQ rev (3m)-326.32%
EPS NY rev (1m)0%
EPS NY rev (3m)62.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 9
P/tB 9
EV/EBITDA N/A
EPS(TTM)-3412.48
EYN/A
EPS(NY)-1.63
Fwd EYN/A
FCF(TTM)-1.55
FCFYN/A
OCF(TTM)-1.55
OCFYN/A
SpS0
BVpS1.03
TBVpS1.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -103.54%
ROE -160.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-66.85%
ROA(5y)-56.8%
ROE(3y)-200.85%
ROE(5y)-609.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.03
Quick Ratio 4.03
Altman-Z -6.12
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.57%
EPS Next Y99.95%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5Y14.87%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-110.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-110.33%
OCF growth 3YN/A
OCF growth 5YN/A

APTEVO THERAPEUTICS INC / APVO FAQ

What is the ChartMill fundamental rating of APTEVO THERAPEUTICS INC (APVO) stock?

ChartMill assigns a fundamental rating of 2 / 10 to APVO.


What is the valuation status of APTEVO THERAPEUTICS INC (APVO) stock?

ChartMill assigns a valuation rating of 1 / 10 to APTEVO THERAPEUTICS INC (APVO). This can be considered as Overvalued.


How profitable is APTEVO THERAPEUTICS INC (APVO) stock?

APTEVO THERAPEUTICS INC (APVO) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for APVO stock?

The Earnings per Share (EPS) of APTEVO THERAPEUTICS INC (APVO) is expected to grow by 99.95% in the next year.